Laws & Regulations

What Does the $6.5 Billion Fraud Takedown Mean for Medicaid?
Regulatory & Compliance What Does the $6.5 Billion Fraud Takedown Mean for Medicaid?

The historic 2026 National Health Care Fraud Takedown has effectively shattered previous records of federal enforcement by uncovering a staggering six and a half billion dollars in fraudulent claims that directly threatened the stability of the American medical safety net. This massive operation,

How Can AI Medical Coding Improve EHR Efficiency?
Regulatory & Compliance How Can AI Medical Coding Improve EHR Efficiency?

The modern healthcare landscape is currently undergoing a profound transformation as institutions transition from the grueling manual labor of traditional data entry toward highly sophisticated autonomous systems. For years, clinical staff and specialized medical coders have struggled against the

Who Qualifies for the $1.8 Million Atrium Health Settlement?
Regulatory & Compliance Who Qualifies for the $1.8 Million Atrium Health Settlement?

The recent finalization of a multimillion-dollar class action settlement involving Atrium Health has brought significant attention to the ongoing vulnerabilities within digital healthcare infrastructures and the legal pathways for patient compensation. This incident, which originated from

Is the 2026 Drug Strategy Building a Surveillance State?
Regulatory & Compliance Is the 2026 Drug Strategy Building a Surveillance State?

The transition of the 2026 National Drug Control Strategy from a medical intervention program into a high-tech surveillance architecture represents a seismic shift in how the federal government monitors the daily lives of American citizens. This 195-page blueprint, ostensibly designed to combat the

Top FDA Official Resigns Amid Gene Therapy Regulatory Shifts
Digital Health Top FDA Official Resigns Amid Gene Therapy Regulatory Shifts

The sudden departure of the Director of the Center for Biologics Evaluation and Research has sent significant shockwaves through the global biotechnology sector, marking a pivotal moment in the governance of high-stakes genetic interventions like CRISPR-based treatments. As the industry moves

Medicare GLP-1 Bridge Program Cuts Weight Loss Drug Costs
Regulatory & Compliance Medicare GLP-1 Bridge Program Cuts Weight Loss Drug Costs

James Maitland brings a unique perspective to the evolving world of healthcare economics, where the rapid advancement of pharmaceutical technology often outpaces traditional insurance frameworks. As a visionary in medical innovation and policy, he has spent years observing how systemic changes

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later